|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 7985 |
FusionGeneSummary for COL6A1_DOT1L |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: COL6A1_DOT1L | Fusion gene ID: 7985 | Hgene | Tgene | Gene symbol | COL6A1 | DOT1L | Gene ID | 1291 | 84444 |
| Gene name | collagen type VI alpha 1 chain | DOT1 like histone lysine methyltransferase | |
| Synonyms | BTHLM1|OPLL|UCHMD1 | DOT1|KMT4 | |
| Cytomap | 21q22.3 | 19p13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | collagen alpha-1(VI) chainalpha 1 (VI) chain (61 AA)collagen VI, alpha-1 polypeptidecollagen, type VI, alpha 1 | histone-lysine N-methyltransferase, H3 lysine-79 specificDOT1 like histone H3K79 methyltransferaseDOT1-like histone methyltransferaseDOT1-like proteinDOT1-like, histone H3 methyltransferaseH3-K79-HMTasehistone H3-K79 methyltransferasehistone methyl | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | P12109 | Q8TEK3 | |
| Ensembl transtripts involved in fusion gene | ENST00000361866, ENST00000498614, | ENST00000398665, ENST00000608122, | |
| Fusion gene scores | * DoF score | 10 X 9 X 6=540 | 7 X 7 X 7=343 |
| # samples | 11 | 8 | |
| ** MAII score | log2(11/540*10)=-2.29545588352617 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/343*10)=-2.10013667128545 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: COL6A1 [Title/Abstract] AND DOT1L [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | DOT1L | GO:0008284 | positive regulation of cell proliferation | 15851025 |
| Tgene | DOT1L | GO:0034729 | histone H3-K79 methylation | 15851025 |
| Tgene | DOT1L | GO:0045944 | positive regulation of transcription by RNA polymerase II | 15851025 |
| Tgene | DOT1L | GO:0046425 | regulation of JAK-STAT cascade | 22002246 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF847866 | COL6A1 | chr21 | 47420141 | + | DOT1L | chr19 | 2219943 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000361866 | ENST00000398665 | COL6A1 | chr21 | 47420141 | + | DOT1L | chr19 | 2219943 | + |
| intron-intron | ENST00000361866 | ENST00000608122 | COL6A1 | chr21 | 47420141 | + | DOT1L | chr19 | 2219943 | + |
| intron-intron | ENST00000498614 | ENST00000398665 | COL6A1 | chr21 | 47420141 | + | DOT1L | chr19 | 2219943 | + |
| intron-intron | ENST00000498614 | ENST00000608122 | COL6A1 | chr21 | 47420141 | + | DOT1L | chr19 | 2219943 | + |
Top |
FusionProtFeatures for COL6A1_DOT1L |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| COL6A1 | DOT1L |
| Collagen VI acts as a cell-binding protein. | Histone methyltransferase. Methylates 'Lys-79' ofhistone H3. Nucleosomes are preferred as substrate compared tofree histones. Binds to DNA. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for COL6A1_DOT1L |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for COL6A1_DOT1L |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for COL6A1_DOT1L |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for COL6A1_DOT1L |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | COL6A1 | C1834674 | Bethlem myopathy | 5 | CTD_human;ORPHANET;UNIPROT |
| Hgene | COL6A1 | C0410179 | Scleroatonic muscular dystrophy | 3 | CTD_human;ORPHANET;UNIPROT |
| Hgene | COL6A1 | C0000786 | Spontaneous abortion | 1 | CTD_human |
| Hgene | COL6A1 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Hgene | COL6A1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
| Hgene | COL6A1 | C0026850 | Muscular Dystrophy | 1 | CTD_human |
| Tgene | DOT1L | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|